{"id":"https://openalex.org/W3206568516","doi":null,"title":"Advances and Prospects in MRNA Vaccines: Modern Horizons Versus New Emerging COVID-19, (SARS-CoV-2)","display_name":"Advances and Prospects in MRNA Vaccines: Modern Horizons Versus New Emerging COVID-19, (SARS-CoV-2)","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3206568516","mag":"3206568516"},"language":"en","primary_location":{"id":"mag:3206568516","doi":null,"is_oa":false,"landing_page_url":"https://www.longdom.org/open-access/advances-and-prospects-in-mrna-vaccines-modern-horizons-versus-newemerging-covid19-sarscov2.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764882758","display_name":"Natural Products Chemistry & Research","issn_l":"2329-6836","issn":["2329-6836"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Natural Products Chemistry & Research","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032593120","display_name":"Maryam Shafaati","orcid":"https://orcid.org/0000-0002-7401-2237","observed_orcids":["https://orcid.org/0000-0002-7401-2237"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maryam Shafaati","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7401-2237","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109234283","display_name":"Niloofar Ahmadi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Niloofar Ahmadi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060552069","display_name":"Hesam Karimi","orcid":"https://orcid.org/0000-0002-6262-4551","observed_orcids":["https://orcid.org/0000-0002-6262-4551"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hesam Karimi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6262-4551","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090127406","display_name":"Amir Pouremamali","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amir Pouremamali","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015652684","display_name":"Ali Teimoori","orcid":"https://orcid.org/0000-0003-0766-8591","observed_orcids":["https://orcid.org/0000-0003-0766-8591"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ali Teimoori","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0766-8591","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5038556144","display_name":"Asghar Abdoli","orcid":"https://orcid.org/0000-0002-1605-4471","observed_orcids":["https://orcid.org/0000-0002-1605-4471","https://orcid.org/0000-0001-7999-2126"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Asghar Abdoli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1605-4471","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.17978824,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"9","first_page":"1","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.8417999744415283,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.8417999744415283,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.1200999990105629,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.01209999993443489,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mrna-vaccines","display_name":"mRNA vaccines","score":1.0},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.921999990940094},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":1.0},{"id":"https://openalex.org/keywords/self-amplifying-mrna","display_name":"self-amplifying mRNA","score":0.9129999876022339},{"id":"https://openalex.org/keywords/mrna-delivery-systems","display_name":"mRNA delivery systems","score":0.8009999990463257},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.5070000290870667},{"id":"https://openalex.org/keywords/vaccine-potency","display_name":"vaccine potency","score":0.4350000023841858},{"id":"https://openalex.org/keywords/emerging-viral-infections","display_name":"emerging viral diseases","score":0.8510000109672546},{"id":"https://openalex.org/keywords/vaccine-production","display_name":"vaccine production","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6571727991104126},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.6100215911865234},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.5970059633255005},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4883362948894501},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.4663756489753723},{"id":"https://openalex.org/C2780441014","wikidata":"https://www.wikidata.org/wiki/Q7907952","display_name":"Vaccine efficacy","level":3,"score":0.4368606209754944},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.42228034138679504},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3778630197048187},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34378135204315186},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3287806808948517},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3268108665943146},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1729128062725067},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.14792177081108093},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12285414338111877},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3206568516","doi":null,"is_oa":false,"landing_page_url":"https://www.longdom.org/open-access/advances-and-prospects-in-mrna-vaccines-modern-horizons-versus-newemerging-covid19-sarscov2.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764882758","display_name":"Natural Products Chemistry & Research","issn_l":"2329-6836","issn":["2329-6836"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Natural Products Chemistry & Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4385516163","https://openalex.org/W4205750622","https://openalex.org/W3113345678","https://openalex.org/W4309175814","https://openalex.org/W3206236720","https://openalex.org/W3213101166","https://openalex.org/W4235785579","https://openalex.org/W3196841693","https://openalex.org/W7155604967","https://openalex.org/W2782708334"],"abstract_inverted_index":{"Over":[0],"the":[1,56,81,97,130,144,150],"past":[2],"two":[3,131],"decades,":[4],"plenty":[5],"of":[6,58,65,83,121,134,166],"measures":[7],"have":[8,49],"been":[9,104],"done":[10],"in":[11,37,78,119],"mRNA":[12,25,66,135,154,167],"based":[13,156,169],"technologies":[14],"for":[15,17,52,106,153],"candidates":[16],"vaccines.":[18],"According":[19],"to":[20,31,73],"pre-clinical":[21],"and":[22,40,55,76,139,148],"clinical":[23,86,146],"trials,":[24],"vaccines":[26,67],"not":[27],"only":[28],"are":[29,45,88],"able":[30],"make":[32],"long-":[33],"term":[34],"immune":[35],"responses":[36],"both":[38],"humans":[39],"animal":[41],"models,":[42],"but":[43],"they":[44,48],"safe.":[46],"Moreover,":[47],"high":[50],"potency":[51],"rapid":[53],"improvement":[54],"process":[57],"their":[59,74],"manufacture":[60],"is":[61,111],"cost-effective;":[62],"nevertheless,":[63],"delivering":[64],"had":[68],"faced":[69],"some":[70],"difficulties":[71],"due":[72],"instability":[75],"inefficient":[77],"vivo.":[79],"During":[80],"write":[82],"this":[84,127,160],"article,":[85],"trials":[87],"currently":[89],"administrated":[90],"by":[91],"monster":[92],"corporations":[93],"vaccine":[94,155,168],"producing":[95],"around":[96],"globe,":[98],"yet":[99],"no":[100],"remedy":[101],"approach":[102],"has":[103],"proved":[105],"new":[107,164],"emerging":[108,122],"SARS-CoV-2.":[109],"Vaccine":[110],"taken":[112],"into":[113],"account":[114],"as":[115],"a":[116,163],"major":[117],"section":[118],"prevention":[120],"viral":[123],"diseases.":[124],"In":[125],"summary,":[126],"review":[128,161],"discusses":[129],"main":[132],"classes":[133],"vaccines:":[136],"conventional":[137],"non\u0002amplifying":[138],"self-amplifying":[140],"mRNA.":[141],"It":[142],"summarizes":[143],"initial":[145],"studies":[147],"outlines":[149],"delivery":[151],"system":[152],"on":[157,170],"technology.":[158],"Finally,":[159],"highlights":[162],"perspective":[165],"technology":[171],"against":[172],"SARS-CoV-2":[173],"(COVID-19).":[174]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2021-10-25T00:00:00"}